SPOT-MAS Multi-Cancer Early Detection Blood Test (In-clinic)
SPOT-MAS Multi-Cancer Early Detection Blood Test (In-clinic)
From S$799.00
Service Overview
SPOT-MAS (Screening for the Presence Of Tumour by Methylation And Size) is a non-invasive, multi-cancer early detection (MCED) blood test that detects tumour DNA (ctDNA) circulating in the blood. This blood test incorporates next-generation sequencing (NGS) and AI technologies to analyse the multiple features of ctDNA, enabling early detection for 10 different types of cancer: 1. Breast 2. Lung 3. Colorectum 4. Stomach 5. Liver-Biliary tract 6. Ovary 7. Pancreas 8. Esophagus 9. Endometrium 10. Head & Neck
Service Description

Note:
This is a complementary screening tool and NOT a subsitute for existing recommended cancer screening and diagnosis methods.
• For more information, please visit:
https://spotmas.com/what-is-the-spot-mas-test/

For full list of health screening services, please visit here.

Recommended for:
Adults above 40 years old
Adults aged less than 40 years old with high risks (e.g. heavy smoking, heavy drinkning, hereditary riks, liver diseases and/or family history)
Adults who are seeking early cancer detection

Not recommended for:
Pregnant women
Individuals who have been diagnosed with cancer in the last 5 years
Individuals experiencing suspected signs and symptoms of cancer
Individuals with history of bone marrow transplant or whole blood transfusion (within 3 months)

Details:
• Non-fasting
• Complimentary doctor's review in clinic

You may also like